A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis
Study title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis
Disease or condition
Eosinophilic esophagitis
Study type
Interventional (clinical trial)
Intervention/treatment
Etrasimod (tablet)
Phase
2
Study site
Duke University
Study location
Durham, NC
Principal investigator
David Leiman, MD
Study coordinator name and email
Chris Efird chris.efird@duke.edu
Phone Contact
919-668-5364
Clinicaltrials.gov link
https://clinicaltrials.gov/ct2/show/NCT04682639